Ariad Pharm Inc (ARIA)
23.99 +0.04 (+0.17%) 02/15/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -231,156 | -162,602 | -274,158 | -220,872 | -123,603 |
| Depreciation Amortization | 12,755 | 8,814 | 4,136 | 8,307 | 4,614 |
| Accounts receivable | -7,290 | -7,092 | -1,305 | 0 | 0 |
| Accounts payable and accrued liabilities | 5,458 | -137 | 2,478 | 2,664 | 2,394 |
| Other Working Capital | 30,019 | 68,240 | 11,756 | 19,809 | 9,618 |
| Other Operating Activity | 30,969 | 34,983 | 35,211 | 36,411 | 53,715 |
| Operating Cash Flow | $-159,245 | $-57,794 | $-221,882 | $-153,681 | $-53,262 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 0 | 45,000 | -45,054 | 0 |
| PPE Investments | -17,205 | -2,787 | -8,543 | -4,424 | -1,452 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -633 | -671 |
| Other Investing Activity | 0 | 4,768 | -10,319 | -922 | -671 |
| Investing Cash Flow | $-17,205 | $1,981 | $26,138 | $-50,400 | $-2,123 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,000 | 200,000 | 0 | 0 | 4,375 |
| Debt Repayment | -1,377 | -9,100 | -2,115 | -1,454 | -1,466 |
| Common Stock Issued | 4,436 | 31,275 | 316,321 | 22,994 | 255,929 |
| Other Financing Activity | 1,198 | -51,115 | -622 | -4,336 | -827 |
| Financing Cash Flow | $54,257 | $171,060 | $313,584 | $17,204 | $258,011 |
| Exchange Rate Effect | 393 | 262 | -40 | 0 | 0 |
| Beginning Cash Position | 352,688 | 237,179 | 119,379 | 306,256 | 103,630 |
| End Cash Position | 230,888 | 352,688 | 237,179 | 119,379 | 306,256 |
| Net Cash Flow | $-121,800 | $115,509 | $117,800 | $-186,877 | $202,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -159,245 | -57,794 | -221,882 | -153,681 | -53,262 |
| Capital Expenditure | -17,205 | -2,787 | -8,543 | -4,424 | -1,452 |
| Free Cash Flow | -176,450 | -60,581 | -230,425 | -158,105 | -54,714 |